Jay Ushin Limited Receives Credit Rating Reaffirmation from CRISIL for ₹125 Crore Bank Facilities

2 min read     Updated on 21 Jan 2026, 12:49 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

CRISIL Ratings reaffirmed Jay Ushin Limited's credit ratings at 'CRISIL BBB-/Stable/CRISIL A3' for ₹125 crore bank facilities. The automotive components manufacturer showed revenue growth to ₹855.20 crores in FY25 with order book exceeding ₹1,100 crores. While the company maintains established market position and reputed clientele, it faces challenges from low profitability margins and moderate financial risk profile.

30525555

*this image is generated using AI for illustrative purposes only.

Jay Ushin Limited has received reaffirmation of its credit ratings from CRISIL Ratings, maintaining its position in the automotive components sector despite facing profitability challenges. The company informed BSE through a regulatory filing dated January 21, 2026, about the rating reaffirmation by CRISIL Ratings.

Credit Rating Details

CRISIL Ratings reaffirmed Jay Ushin Limited's credit ratings for bank loan facilities worth ₹125.00 crores. The rating action maintains the company's financial standing in the market.

Rating Type: Rating Status
Long Term Rating: CRISIL BBB-/Stable Reaffirmed
Short Term Rating: CRISIL A3 Reaffirmed
Total Facilities Rated: ₹125.00 crores -

Financial Performance and Business Strengths

The automotive components manufacturer demonstrated strong revenue growth, with operating income increasing to ₹855.20 crores in FY25 from ₹726.25 crores in FY24. The company has established a strong market position through over three decades of promoter experience and healthy customer relationships.

Financial Metric: FY25 FY24 Performance
Operating Income: ₹855.20 crores ₹726.25 crores Growth
Revenue till June 2025: ₹214.13 crores - -
Revenue till September 2025: ₹242.27 crores - -
Order Book: Over ₹1,100 crores - Strong

Jay Ushin serves as a Tier-1 supplier to major 4-wheeler and 2-wheeler original equipment manufacturers, with 70-75% sales from 4-wheeler segment and 20-25% from 2-wheeler segment. The company maintains 99% domestic sales and 1% exports to Suzuki Japan.

Key Rating Drivers and Challenges

CRISIL Ratings highlighted the company's established market position and reputed clientele as key strengths. Nearly half the revenue comes from the top 3 customers, who are leading OEMs in India. The company's association with JPM Group and dominance in the Indian market provides revenue visibility.

However, the ratings also reflect certain weaknesses:

Low Profitability: Operating margins remained at 3-4% through fiscal 2024 • Moderate Financial Risk: Overall gearing at 1.13 times and TOLANW ratio at 2.39 times as of March 31, 2025 • Interest Coverage: Interest coverage ratio at 2.25 times for fiscal 2025

Liquidity and Financial Metrics

The company maintains adequate liquidity with moderate bank limit utilization at around 67% for the twelve months ended November 2025. Cash accruals are expected to be ₹30-35 crores, sufficient against term debt obligations of ₹9-18 crores over the medium term.

Key Ratio: FY25 FY24
PAT Margin: 1.43% 1.97%
Adjusted Debt/Adjusted Networth: 1.13 times 1.34 times
Interest Coverage: 2.25 times 1.85 times
Current Ratio: 0.92 times -

Company Background and Operations

Incorporated in 1986, Jay Ushin Limited operates as a joint venture between the JPM group and U-Shin Ltd, Japan. The company manufactures automotive components including lock and key sets, combination switches, heater control panels, and door latches. It operates manufacturing units across Gujarat, Chennai, Bengaluru, Manesar, Jharsa in Haryana, and Bhiwadi in Rajasthan, with headquarters in Gurugram.

Historical Stock Returns for Jay Ushin

1 Day5 Days1 Month6 Months1 Year5 Years
-0.15%-5.45%-1.64%+37.35%+31.86%+75.82%
Jay Ushin
View in Depthredirect
like16
dislike

New Zealand PM Hails India FTA Benefits as AYUSH Gets Trade Recognition

1 min read     Updated on 04 Jan 2026, 09:03 PM
scanx
Reviewed by
Shraddha JScanX News Team
Overview

New Zealand Prime Minister Christopher Luxon has praised the Free Trade Agreement with India, emphasizing its potential to boost exports and create opportunities for farmers and businesses, with a USD 20 billion FDI commitment over 15 years. The landmark deal also provides formal recognition to India's traditional medicine system AYUSH, which has shown strong export growth of 6.11% to ₹5,747.42 crores in 2024-25.

29086398

*this image is generated using AI for illustrative purposes only.

India's Free Trade Agreement with New Zealand has received strong endorsement from New Zealand Prime Minister Christopher Luxon, who emphasized the deal's potential to boost exports and create opportunities for farmers and businesses. The agreement, which also provides formal recognition to India's traditional medicine system AYUSH, represents a significant milestone in bilateral trade relations.

Prime Minister's Endorsement

New Zealand Prime Minister Christopher Luxon highlighted the transformative potential of the recently finalized FTA with India. Speaking about the agreement, Luxon stated that it "will open doors for New Zealand farmers, growers, and businesses – boosting exports, creating jobs, and lifting incomes to help all Kiwis get ahead."

Agreement Features: Details
Implementation Timeline: 7-8 months
FDI Commitment: USD 20 billion over 15 years
Market Access: Enhanced for farmers and businesses
Economic Impact: Job creation and income growth

Describing the FTA as a "landmark deal" with the world's fastest-growing big economy, Luxon emphasized that his government has worked extremely hard to prioritize the relationship with India since day one.

AYUSH Recognition and Export Growth

The India-New Zealand FTA features dedicated provisions for traditional medicine systems, providing formal recognition to India's AYUSH sector. This recognition comes alongside robust export performance in the traditional medicine sector.

AYUSH Export Performance: Value Growth
2023-24: ₹5,410.98 crores -
2024-25: ₹5,747.42 crores +6.11%

The agreement includes dedicated annexures on health-related services and traditional medicine, creating structured pathways for enhanced market access and streamlined regulatory frameworks.

Strategic Trade Context

This FTA represents India's third major trade agreement in recent months, following similar pacts with the UK and Oman. The timing is particularly significant as it provides Indian exporters with opportunities to diversify shipments in the Oceania region, especially relevant given recent global trade challenges.

Luxon described India as a "trusted partner," noting that the trade deal will deliver deep and lasting benefits for New Zealand. The agreement aims to enhance market access and promote investment flows between the two nations, positioning both countries for sustained economic growth through strengthened bilateral cooperation.

Historical Stock Returns for Jay Ushin

1 Day5 Days1 Month6 Months1 Year5 Years
-0.15%-5.45%-1.64%+37.35%+31.86%+75.82%
Jay Ushin
View in Depthredirect
like20
dislike
More News on Jay Ushin
Explore Other Articles
879.00
-1.30
(-0.15%)